Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Higher Ed Restructuring Act Is Transforming Rowan University

Glassboro, NJ, July 3, 2014NJBIZ’s Andrew Sheldon reports that the New Jersey Medical and Health Sciences Education Restructuring Act has, within its first year, brought changes that Rowan University President Dr. Ali Houshmand is calling “the most tremendous and promising transformation we have celebrated in our 90-year history.”

One major change was the addition of the Graduate School of Biomedical Sciences.  With this addition, Rowan has become only the second university in the nation to have schools offering both M.D. and D.O. medical degrees.

The legislation, which took effect July 1, 2013, also designated the University as the state’s second comprehensive public research facility.  This designation is “a milestone that opens many doors for our university,” Dr. Houshmand said.

The designation has Rowan looking ahead and developing new doctoral programs; it hopes to add engineering and psychology to its already existing cell and molecular biology Ph.D. programs.

The plans for these programs include collaboration with Rutgers-Camden and are supplemented by additional undergraduate and graduate courses.

The designation also has increased Rowan’s visibility as an economic driver:  Since the Restructuring Act went into effect a year ago, the university has received more than $18.4 million in sponsored program grants and various contracts.  This number is up 65 percent from 2013.

For the complete NJBIZ story, click here.